Literature DB >> 9331153

Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat.

A Tari1, T Kamiyasu, Y Yonei, M Hamada, M Sumii, K Sumii, G Kajiyama, R Dimaline.   

Abstract

The aim of this study was to investigate whether gastrin regulates morphological changes and alpha-subunit gene expression in parietal cells through the gastrin/CCK-B receptor on enterochromaffin-like cells by histamine release. Treatment with 100 mg/kg of YM022, a potent and selective gastrin/CCK-B receptor antagonist, for one week in rats did not alter mRNA levels of histidine decarboxylase or H+, K+-ATPase. However, parietal cell morphology predominantly changed to the resting form, although the serum gastrin concentration was significantly increased. Additional treatment with YM022 and oral omeprazole, 100 mg/kg, for one week markedly suppressed the increases of mRNA levels of histidine decarboxylase and H+, K+-ATPase and completely blocked the morphological transformation of the parietal cells to a stimulated form induced by treatment with omeprazole alone. This indicates that the morphological transformation of parietal cells to an activated form with a subsequent increase in H+, K+-ATPase synthesis caused by hypergastrinemia is mediated by increased histidine decarboxylase gene expression in enterochromaffin-like cells via gastrin/CCK-B receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331153     DOI: 10.1023/a:1018863227013

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

Review 2.  Role of gastrin as a trophic hormone.

Authors:  J H Walsh
Journal:  Digestion       Date:  1990       Impact factor: 3.216

3.  Expression of the gastric H+/K(+)-ATPase and histidine decarboxylase during omeprazole treatment.

Authors:  B Swarovsky; R Eissele; M Gross; G Körtner; H Koop; R Arnold; B Simon
Journal:  Digestion       Date:  1994       Impact factor: 3.216

4.  Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells.

Authors:  S M Karam; J G Forte
Journal:  Am J Physiol       Date:  1994-04

5.  Effect of histamine on rat gastric H(+)-K(+)-ATPase alpha-subunit expression.

Authors:  A Tari; G Yamamoto; Y Yonei; M Sumii; K Sumii; K Haruma; G Kajiyama; V Wu; G Sachs; J H Walsh
Journal:  Am J Physiol       Date:  1994-03

6.  Role of histamine2 receptor in increased expression of rat gastric H(+)-K(+)-ATPase alpha-subunit induced by omeprazole.

Authors:  A Tari; G Yamamoto; K Sumii; M Sumii; Y Takehara; K Haruma; G Kajiyama; V Wu; G Sachs; J H Walsh
Journal:  Am J Physiol       Date:  1993-10

7.  YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.

Authors:  A Nishida; Y Takinami; H Yuki; A Kobayashi; S Akuzawa; T Kamato; H Ito; M Yamano; Y Nagakura; K Miyata
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

8.  Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats.

Authors:  F Sundler; E Carlsson; R Håkanson; H Larsson; H Mattsson
Journal:  Scand J Gastroenterol Suppl       Date:  1986

9.  Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation.

Authors:  D Chen; H J Monstein; A G Nylander; C M Zhao; F Sundler; R Håkanson
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

10.  Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.

Authors:  J Stachura; S J Konturek; M Cieszkowsky; W Dabroś; J Zakrzewska; J Konturek
Journal:  Hepatogastroenterology       Date:  1983-10
View more
  2 in total

1.  Acid peptic diseases: pharmacological approach to treatment.

Authors:  Alex Mejia; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2009-05       Impact factor: 5.045

2.  The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

Authors:  Dominic-Luc Webb; Tobias Rudholm-Feldreich; Linda Gillberg; Md Abdul Halim; Elvar Theodorsson; Gareth J Sanger; Colin A Campbell; Malcolm Boyce; Erik Näslund; Per M Hellström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-24       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.